Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Jiangsu Jiuding New Material Co., Ltd. (002201.SZ)
Rugao, CN
Jiangsu Jiuding New Material Co., Ltd. specializes in the production and distribution of various glass fiber products, including yarn, textiles, and finished goods. Its operations further encompass the design, manufacturing, marketing, and installation of fiberglass reinforced plastic (FRP) items. Additionally, the company offers products made from diverse industrial fibers, alongside materials for both structural and ornamental reinforcement. Established in June 1994, the firm maintains its headquarters in Rugao, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -6.19% | -5.47% | -20.72% | -19.68% | +38.42% | -3.15% | +74.45% | +9.07% | +37.73% | +141.48% | +83.11% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+25.3% ★ Q1'26: +4.1% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+180.0% ★ Q1'26: -4.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+3.1% ★ Q1'26: +15.3% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+9.6% ★ Q1'26: +8.8% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+6.5% ★ Q1'26: +5.3% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+10.3% Q1'26: -0.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×1.93× Q1'26: 5.03× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-28 | B- | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-27 | B- | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-26 | B- | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-25 | B- | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-22 | B- | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-21 | B- | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-20 | B- | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-19 | B- | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-18 | B- | 2/5 | 2/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-15 | B- | 2/5 | 2/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-14 | B- | 2/5 | 2/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-13 | B- | 2/5 | 2/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-12 | B- | 2/5 | 2/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-11 | B- | 2/5 | 2/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-08 | C+ | 2/5 | 2/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C+ | 2/5 | 2/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C+ | 2/5 | 2/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | B- | 2/5 | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | B- | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | B- | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | B- | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | B- | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 265.6K | 0.29% |
| 2 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 330.8K | 0.06% |
| 3 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 98.9K | 0.39% |
| 4 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 9.3K | 0.48% |
| 5 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 21.0K | 0.26% |
| 6 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 1.03M | 0.06% |
| 7 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 26.9K | 0.28% |
| 8 | Vanguard Total International Stock ETF VXUS | 0.00% | 923.1K | 0.05% |
| 9 | Vanguard FTSE Global All Cap ex Canada Index ETF VXC.TO | 0.00% | 1.7K | 0.22% |
| 10 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 5.0K | 0.22% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Cheng Chen | Executive Vice President of the Settlement Center | — | male |
| Fan Xiangyang | Deputy General Manager | — | male |
| Haiyan Liu | Accounting Supervisor | — | — |
| Roujian Gu | Vice Chairman & GM | — | male |
| Xiuhua Han | Chief Financial Officer & Head of the Finance Department | — | male |
| Zhen Miao | Vice Chairman & Secretary to the Board | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002201.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
